Aminalon tablets p/o 250mg №10×5

Name:
Aminalon tablets 250 mg in a cell. pack No. 10×5
Description:
Coated tablets of white or almost white color, biconvex. Composition One tablet contains: active ingredient: gamma-aminobutyric acid – 250 mg; excipients: sucrose, povidone, magnesium stearate, opadry II (including partially hydrolyzed polyvinyl alcohol, talc, macrogol 3350 (polyethylene glycol), lecithin (soy), titanium dioxide E 171), baking wheat flour, basic light magnesium carbonate , titanium dioxide E 171, yellow beeswax, hard paraffin, refined sunflower oil. Pharmacotherapeutic group Other psychostimulants and nootropics. ATX code: N06BX. Pharmacological propertiesPharmacodynamics A nootropic agent that improves the metabolic processes of brain tissues, promotes the utilization of glucose by the brain and the removal of toxic metabolic products from it. It increases the productivity of thinking, improves memory, has a moderate psychostimulating effect, favorably affects the restoration of movements and speech after a violation of cerebral circulation. It has a mild hypotensive effect, reduces initially high blood pressure and the severity of symptoms caused by hypertension (dizziness, insomnia), slightly slows down the heart rate. It has a moderate antihypoxic and anticonvulsant effect. In patients with diabetes mellitus, it reduces the content of glucose, with a normal content of glucose in the blood, it has the opposite effect (due to glycogenolysis). Pharmacokinetics Absorption – fast, fairly complete. The time to reach the maximum concentration in the blood plasma is 60 minutes, then the concentration decreases rapidly and after 24 hours in the blood plasma is not determined. Indications for use Conditions after suffering cerebrovascular accidents and craniocerebral injuries; psychoorganic syndrome; atherosclerotic, hypertensive and alcoholic encephalopathy; cerebral palsy and the consequences of birth trauma in children as part of complex therapy; mental retardation in children; kinetosis (sea and air sickness ). Adults and children over 7 years of age are prescribed orally 0.5-1.25 g 3 times a day. Daily dose – 1.5-3 g. Children aged 6 years – 2.0-3.0 g / day (8-12 tablets) in 3 divided doses. The course of treatment is at least 2-3 weeks (optimally 2-4 months). If necessary, courses are repeated 1-2 times a year. In the treatment of kinetosis, adults are prescribed 0.5 g (2 tablets), children 0.25 g (1 tablet) 3 times a day for 3-4 days preceding the trip. Side effects nausea, vomiting, dyspepsia; fever, feeling hot; insomnia; allergic reactions; blood pressure lability. Interaction with other drugs With simultaneous use, it is possible to increase the inhibitory effect on the central nervous system of benzodiazepine derivatives, anticonvulsants and sedative-hypnotic drugs. Enhances the effect of antihypertensive drugs while using them. When used together with vinpocetine, nimodipine, nicergoline in the elderly, hypotension and aggravation of cerebrovascular accidents may develop due to the development of cerebral hypoperfusion against the background of hypotension. Precautions This medicinal product contains sucrose and should not be taken by patients with hereditary fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase deficiency. Caution when using Aminalon should be used with extreme caution in patients with labile blood pressure in the first days of treatment, due to the possibility of significant fluctuations in blood pressure. Pregnancy and lactation During pregnancy and lactation, the safety and efficacy of Aminalon have not been established. Features of the effect of the drug on the ability to drive vehicles or potentially dangerous mechanisms When using Aminalon, care must be taken when driving vehicles or potentially dangerous mechanisms. Overdose Aminalon has low toxicity. Symptoms of intoxication occur only with the simultaneous use of extremely high doses of aminalon (more than 10-20 g) and are characterized by the following symptoms: nausea, vomiting, stomach pain, fever, headache, drowsiness and bradycardia. Treatment. There is no specific antidote. Assistance measures include the abolition of the drug, gastric lavage with activated charcoal, the appointment of enveloping agents (diosmectite, starch mucus), supportive and symptomatic therapy aimed at eliminating the disorders that have arisen. Upakovka10 tablets in a blister pack of PVC film and aluminum foil. 5 or 10 blister packs, together with the leaflet, are placed in a pack of cardboard. Storage conditions In a place protected from light and moisture, at a temperature not exceeding 25 ° C. Keep out of the reach of children. Shelf life 3 years. Do not use after the expiration date. Terms of dispensing from pharmacies By prescription. Buy Aminalon tablets p/o 250mg №10×5 Price for Aminalon tablets p/o 250mg №10×5